Fig. 3From: Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cellsmRNA levels of MAPK and survival pathway members. Two-fold or more differences compared to control cells were evaluated by RT2-PCR array. Group 1: DMSO Control versus Quercetin; Group 2: DMSOcontrol versus Quercetin + CisplatinBack to article page